Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus

被引:91
作者
Invernizzi, R [1 ]
Velasco, C [1 ]
Bramante, M [1 ]
Longo, A [1 ]
Samanin, R [1 ]
机构
[1] IST RIC FARMACOL MARIO NEGRI, MILAN, ITALY
关键词
5-HT1A receptor; 5-HT1B receptor; SSRI; dorsal hippocampus; frontal cortex; striatum; dialysate; 5-HT; antidepressant activity; microdialysis;
D O I
10.1016/S0028-3908(97)00060-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of the present study was to compare the effects of citalopram, either alone or combined with 5-HT1A receptor antagonists, on extracellular serotonin levels in brain regions innervated by the dorsal or median raphe nuclei. Using intracerebral microdialysis in awake rats with separate probes in the frontal cortex or dorsal hippocampus, we studied the ability of 8 mg/kg s.c. (-)penbutolol, a beta-adrenoceptor antagonist with antagonist action at 5-HT1A and 5-HT1B receptors, and 0.3 mg/kg s.c. WAY-100635, a selective 5-HT1A receptor blocker, to modify the effect of 1 and 10 mg/kg i.p. citalopram on extracellular serotonin. Both doses of citalopram had more effect on extracellular serotonin levels in the dorsal hippocampus than in the frontal cortex. The effect of 1 mg/kg citalopram was significantly potentiated by (-)penbutolol in the frontal cortex only, but a clear-cut potentiation of the effect of citalopram was seen in both regions at a dose of 10 mg/kg. The effect of 10 mg/kg citalopram was potentiated by WAY-100635 in the frontal cortex but not in the dorsal hippocampus. In a second set of experiments, the combined effect of WAY-100635 and citalopram was studied in the same rat implanted with vertical probes in the striatum and dorsal hippocampus. Citalopram (1 and 10 mg/kg i.p.) raised extracellular serotonin to a similar extent in both regions. However, 0.3 mg/kg s.c. WAY-100635 potentiated the effect of 10 mg/kg citalopram in the striatum but not in the dorsal hippocampus. The results suggest that only a combined blockade of 5-HT1A and 5-HT1B receptors potentiates the effect of citalopram on extracellular concentrations of serotonin in the dorsal hippocampus. The findings may be relevant in designing clinical trials aimed at enhancing the antidepressant action of selective serotonin re-uptake inhibitors by combining them with serotonin receptor antagonists. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:467 / 473
页数:7
相关论文
共 34 条
[11]   SEROTONIN RELEASE ESTIMATED BY TRANSCORTICAL DIALYSIS IN FREELY-MOVING RATS [J].
CARBONI, E ;
DICHIARA, G .
NEUROSCIENCE, 1989, 32 (03) :637-645
[12]  
DEMONTIGNY C, 1993, INT ACAD B, V5, P8
[13]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88
[14]   BIOCHEMICAL HYPOTHESES ON ANTIDEPRESSANT DRUGS - A GUIDE FOR CLINICIANS OR A TOY FOR PHARMACOLOGISTS [J].
GARATTINI, S ;
SAMANIN, R .
PSYCHOLOGICAL MEDICINE, 1988, 18 (02) :287-304
[15]   INTERACTION BETWEEN A SELECTIVE 5-HT1A RECEPTOR ANTAGONIST AND AN SSRI IN-VIVO - EFFECTS ON 5-HT CELL FIRING AND EXTRACELLULAR 5-HT [J].
GARTSIDE, SE ;
UMBERS, V ;
HAJOS, M ;
SHARP, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :1064-1070
[16]  
Gurling J., 1994, British Journal of Pharmacology, V112, p299P
[17]  
HAJOS M, 1995, N-S ARCH PHARMACOL, V351, P624
[18]   FURTHER EVIDENCE FOR THE IMPORTANCE OF 5-HT1A AUTORECEPTORS IN THE ACTION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS [J].
HJORTH, S ;
AUERBACH, SB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 260 (2-3) :251-255
[19]  
HJORTH S, 1993, J PHARMACOL EXP THER, V265, P707
[20]   SEROTONIN 5-HT1A AUTORECEPTOR BLOCKADE POTENTIATES THE ABILITY OF THE 5-HT REUPTAKE INHIBITOR CITALOPRAM TO INCREASE NERVE-TERMINAL OUTPUT OF 5-HT INVIVO - A MICRODIALYSIS STUDY [J].
HJORTH, S .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) :776-779